SCHEMBL9941002

SCHEMBL9941002

CCOC(C)CNc1nccn2c(-c3ccc(C(N)=O)c(O)c3C3CC3)cnc12

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TTK P33981 20/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9942395 0.92 TTK (0.47) TTK
SCHEMBL9941106 0.87 TTK (0.45) TTK
SCHEMBL9940957 0.86 TTK (0.54) TTK
SCHEMBL9941206 0.83 TTK (0.42) TTK
SCHEMBL9941032 0.81 TTK (0.51) TTK
SCHEMBL9940878 0.80 TTK (0.46) TTK
SCHEMBL9941302 0.79 TTK (0.43) TTK
SCHEMBL9941323 0.78 TTK (0.57) TTK
SCHEMBL9941040 0.78 TTK (0.41) TTK
SCHEMBL9942359 0.78 TTK (0.47) TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651948-A1 IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT HYPERPROLIFERATIVE DISORDERS Bayer Intellectual Property GmbH (DE) 2013-10-23 EP claimed
WO-2012080229-A1 IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT HYPERPROLIFERATIVE DISORDERS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-06-21 WO claimed